30|day mortality after the start of systemic anticancer therapy for lung ...

30-day mortality after the start of systemic anticancer therapy for lung ...

30-day mortality rate after first-line systemic therapy for lung cancer does not seem to be a meaningful indicator to monitor quality of care.

30-day mortality after the start of systemic anticancer therapy for lung ...

27% involved small cell lung cancer and 73% nonsmall cell lung cancer. Overall mortality within 30 days after the start of systemic treatment ...

30-day mortality after systemic anticancer treatment for breast and ...

Patients dying within 30 days after beginning treatment with SACT are unlikely to have gained the survival or palliative benefits of the ...

Thirty-Day Mortality Following Systemic Anticancer Therapy

We defined an indicator adapted to the clinical context evaluating 30-day mortality following SACT. This indicator can be used to identify risk ...

Is 30-day mortality after systemic anticancer therapy in lung cancer ...

Background: Death within 30 days of systemic anticancer therapy (SACT) is a national benchmark of quality of care in England. This metric has mobilised changes ...

Utility of 30-Day Mortality Following Systemic Anti-Cancer Treatment ...

1072 patients were identified. Annual 30-day mortality rate after palliative-intent SACT for lung cancer ranged between 9% and 15%, with significant variance ...

EP.15B.05 Predictors of 30-Day Mortality after Systemic Therapy in ...

A total of 144 lung cancer patients were consecutively enrolled; 14 (9.7%) patients did not start anticancer treatment and were excluded from the study.

Thirty-Day Mortality Following Systemic Anticancer Therapy

We defined an indicator adapted to the clinical context evaluating 30-day mortality following SACT. This indicator can be used to identify risk factors.

Thirty-Day Mortality Following Systemic Anticancer Therapy

For lung, pancreatic and prostate cancer, patients were pre- dominantly given palliative SACTs (87%, 88% and 98%, respectively). In contrast, breast cancer ...

Intensity of end-of-life health care and mortality after systemic anti ...

0.8 and 2.5% of SACT patients had died within 14 and 30 days after the treatment decision, respectively, compared with the 24 and 41% in the no- ...

30-day mortality after systemic anticancer treatment for breast and ...

Methods In this population-based study, we included all women with breast cancer and all men and women with lung cancer residing in England, who ...

30-day mortality after systemic anti-cancer therapy (SACT)

Among the most commonly treated cancers, those with more than 1,000 patients treated in 2023, the highest SACT 30-day mortality was recorded for ...

Trust-level 30-day mortality after systemic anticancer treatment for ...

we described the use of NHS systemic anticancer therapy (SACT) information on a national scale to examine deaths among lung and breast ...

1378P Is 30-day mortality after systemic anticancer therapy in lung ...

This is the first study to analyse 30-day mortality after lung cancer SACT according to all treatment types.

30-day mortality after the start of systemic anticancer therapy for lung ...

In the Netherlands, the 30-day mortality rate after start of systemic therapy for lung cancer patients was comparable with earlier reports and does not seem ...

(PDF) 30-day mortality after the start of systemic anticancer therapy ...

PDF | Systemic treatment is the standard treatment for unresectable stage III and IV lung cancer. Nevertheless, a 5–10% death rate has been described.

30-day mortality after systemic anticancer treatment for breast and ...

Background 30-day mortality might be a useful indicator of avoidable harm to patients from systemic anticancer treatments, but data for this ...

Retrospective analysis of mortality within 30 days of systemic ...

Burgers JA, Damhuis RA. 30-day mortality after the start of systemic anticancer therapy for lung cancer: is it really a useful performance ...

Mortality Within 30 Days of Administration of a Systemic Anticancer ...

Burgers JA, Damhuis RA. 30-day mortality after the start of systemic anticancer therapy for lung cancer: is it really a useful performance ...

Utility of 30-Day Mortality Following Systemic Anti-Cancer Treatment ...

1072 lung cancer patients on palliative-intent treatment were identified. • Targeted therapy and immunotherapy were more often given within 30 days of death ...